Skip to main content

Peer Review reports

From: Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial

Original Submission
30 Jul 2020 Submitted Original manuscript
30 Jul 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
30 Jul 2020 Editorially accepted
8 Aug 2020 Article published 10.1186/s13063-020-04647-x

You can find further information about peer review here.

Back to article page